Sale

Emphysema Treatment Market

Global Emphysema Treatment Market Size, Share, Trends, Report: By Diagnosis: Imaging Test, Lab Test, Spirometry, Others; By Type: Centriacinar, Panacinar, Paraseptal, Others; By Treatment Type; By Route of Administration; By Treatment Channel; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Emphysema Treatment Market Outlook

The global emphysema treatment market size was valued at USD 4.65 billion in 2023, driven by increased utilisation of advanced safety products in sectors like oil and gas and chemicals, rising product demand from the developing regions, implementation of strict regulatory policies by the governments across the nations, and growing technological advancements. The market is anticipated to grow at a CAGR of 5.7% during the forecast period 2024-2032 to reach a value of USD 7.66 billion by 2032.

 

Global Emphysema Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Significantly Contribute to the Emphysema Treatment Industry

North America accounts for a significant share in the industry owing to the growing cases of chronic obstructive pulmonary diseases (COPD) in the region and the availability of improved healthcare facilities. According to estimates, COPD is one of the leading causes of deaths in the United States. North America is followed by Europe. The availability of diagnostic services for respiratory illness is propelling the industry growth in the European region. Meanwhile, the growing presence of smoking population and the rising pollution levels in the Asia Pacific are expected to create new opportunities for the market expansion in the forecast period.

 

Emphysema Treatment: Market Segmentation

Emphysema, which is a type of chronic obstructive pulmonary disease (COPD), is a lung condition that leads to the shortness of breath due to the damage caused to the air sacs (alveoli) in the lungs. The patient suffering from emphysema can be treated by improving shortness of breath.

 

Global Emphysema Treatment Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By treatment, the market is divided into:

  • Smoking Cessation
  • Bronchodilators
  • Steroids
  • Leukotriene Modifiers
  • Supplemental Oxygen
  • Antibiotics
  • Gene Therapy
  • Surgery Transplant
  • Others

Based on types of diseases, the industry can be segmented into:

  • Shortness of Breath
  • Chronic Cough
  • Chronic Mucus Production
  • Chest Tightness
  • Wheezing
  • Fatigue
  • Lowered Immunity
  • Weight Loss
  • Thin and Very Pink Skin
  • Others

Based on end use, the industry can be categorised into:

  • Hospital
  • Clinics
  • Surgical Centre
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Emphysema Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increase in the Number of Smokers Globally to Augment the Emphysema Treatment Industry Growth

The increase in the number of tobacco smokers is driving the growth of the emphysema treatment industry. The growing prevalence of chronic lung disorders and the availability of advanced diagnostic facilities are resulting in the increased demand for treatment for emphysema. Other factors such as the sedentary lifestyle, growing urbanisation and industrialisation, and rising pollution levels are further propelling the industry growth. Over the forecast period, the growing R&D activities and the advancements in the medical sector are expected to drive the growth of the global emphysema treatment industry.

 

Key Industry Players in the Global Emphysema Treatment Market

The report gives a detailed analysis of the following key players in the global emphysema treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Pulmonx Corporation
  • Kamada Limited
  • Pfizer Inc.
  • Uptake Medical Technology Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnosis
  • Type
  • Treatment Type
  • Route of Administration
  • Treatment Channel
  • End User
  • Distribution Channel
  • Region
Breakup by Diagnosis
  • Imaging Test
  • Lab Test
  • Spirometry
  • Others
Breakup by Type
  • Centriacinar
  • Panacinar
  • Paraseptal
  • Others
Breakup by Treatment Type
  • Medication
  • Surgery
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Breakup by Treatment Channel
  • Public
  • Private
Breakup by End User
  • Hospitals
  • Homecare
  • Specialty Centres
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Bristol Myers Squibb Company
  • GSK Plc.
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd.
  • Intersect ENT, Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Emphysema Overview 

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Emphysema Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Emphysema Epidemiology (2016-2031)
    5.3    Europe Emphysema Epidemiology (2016-2031)
    5.4    Asia-Pacific Emphysema Epidemiology (2016-2031)
    5.5    Latin America Emphysema Epidemiology (2016-2031)
    5.6    Middle East & Africa Emphysema Epidemiology (2016-2031)
6    Global Emphysema Market Overview 
    6.1    Global Emphysema Market Historical Value (2017-2023) 
    6.2    Global Emphysema Market Forecast Value (2024-2032)
7    Global Emphysema Market Landscape
    7.1    Global Emphysema Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Global Emphysema Product Landscape
        7.2.1    Analysis by Treatment Type
        7.2.2    Analysis by Route of Administration
        7.2.3    Analysis by End User
8    Emphysema Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Emphysema Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Emphysema Market Segmentation
    11.1    Global Emphysema Market by Diagnosis
        11.1.1    Market Overview
        11.1.2    Imaging Test
        11.1.3    Lab Test
        11.1.4    Spirometry
        11.1.5    Others
    11.2    Global Emphysema Market by Type
        11.2.1    Market Overview
        11.2.2    Centriacinar
        11.2.3    Panacinar
        11.2.4    Paraseptal
        11.2.5    Others
    11.3    Global Emphysema Market by Treatment Type
        11.3.1    Market Overview
        11.3.2    Medication
            11.3.2.1    Bronchodilators
            11.3.2.2    Steroids
            11.3.2.3    Others
        11.3.3    Surgery
        11.3.4    Others
    11.4    Global Emphysema Market by Route of Administration
        11.4.1    Market Overview
        11.4.2    Oral
        11.4.3    Parenteral
        11.4.4    Others
    11.5    Global Emphysema Market by Treatment Channel
        11.5.1    Market Overview
        11.5.2    Public
        11.5.3    Private
    11.6    Global Emphysema Market by End User
        11.6.1    Market Overview
        11.6.2    Hospitals
        11.6.3    Homecare
        11.6.4    Specialty Centres
        11.6.5    Others
    11.7    Global Emphysema Market by Distribution Channel
        11.7.1    Market Overview
        11.7.2    Hospital Pharmacy
        11.7.3    Online Pharmacy
        11.7.4    Retail Pharmacy
    11.8    Global Emphysema Market by Region
        11.8.1    Market Overview
        11.8.2    North America
        11.8.3    Europe 
        11.8.4    Asia Pacific
        11.8.5    Latin America
        11.8.6    Middle East and Africa
12    North America Emphysema Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Emphysema Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Emphysema Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Emphysema Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Emphysema Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Pfizer Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    F. Hoffmann-La Roche Ltd.
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Mylan N.V.
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Fresenius Kabi AG
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Hikma Pharmaceuticals PLC 
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Novartis AG
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Teva Pharmaceutical Industries Ltd.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Bristol Myers Squibb Company
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    GSK Plc.
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Bayer AG
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Sun Pharmaceutical Industries Ltd.
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Intersect ENT, Inc.
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
24    Global Emphysema Market- Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global emphysema treatment market reached a value of USD 4.65 billion in 2023.

The market is projected to grow at a CAGR of 5.7% during the forecast period of 2024-2032 to reach a value of USD 7.66 billion by 2032.

The major drivers of the industry, such as the rising pollution levels, increasing smoking population, developing healthcare facilities, increasing prevalence of chronic obstructive pulmonary diseases, and escalating disposable incomes, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing investments in R&D activities and the advancing medical sector.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading treatment types in the market are smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, and surgery transplant, among others.

The major types of diseases considered in the market are shortness of breath, chronic cough, chronic mucus production, chest tightness, wheezing, fatigue, lowered immunity, weight loss, and thin and very pink skin, among others.

The significant end use sectors in the industry are hospital, clinics, and surgical centre, among others.

The major players in the industry are Pulmonx Corporation, Kamada Limited, Pfizer Inc., and Uptake Medical Technology Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER